Objectives: Our aim was to study the antimicrobial susceptibilities and macrolide resistance mechanisms of viridans group streptococci (VGS) in a Korean tertiary hospital. Conclusions: Penicillin non-susceptible VGS were more resistant to erythromycin, clindamycin and ceftriaxone than were penicillin-susceptible isolates. A constitutive MLS B phenotype associated with erm(B) was the predominant mechanism of macrolide resistance among erythromycin non-susceptible isolates from this Korean hospital.
Introduction
The viridans group streptococci (VGS) make up a heterogeneous group of streptococci that normally inhabit the mouth, gastrointestinal tract and female genital tract. They are often considered to be contaminants when isolated from blood cultures. However, they are also the leading cause of subacute bacterial endocarditis, and commonly cause catheter-and neutropenia-related bloodstream infections. β-Lactam agents are the treatment of choice for these infections, but increasing resistance to penicillin has recently been reported in many parts of the world. 1 Macrolides and related drugs have been suggested as alternatives, but recent studies have shown that macrolide resistance may also be a problem. 1 The objectives of the present study were to determine the incidence and patterns of antimicrobial resistance among VGS isolated from blood cultures in a Korean hospital and to clarify the macrolide resistance phenotypes and genotypes of erythromycin non-susceptible isolates. were stored in brain-heart infusion broth plus 20% glycerol at -70°C until studied.
Materials and methods
Susceptibility to penicillin G, erythromycin, clindamycin, ceftriaxone (Sigma Chemical Co., St Louis, MO, USA) and vancomycin (Daewoong Lilly, Korea) was determined by an agar dilution method, 2 and MICs were interpreted using NCCLS criteria. 3 Macrolide resistance phenotypes of erythromycin non-susceptible isolates were determined using a double-disc test with erythromycin (15 µg) and clindamycin (2 µg) discs on Mueller-Hinton agar plates containing 5% sheep blood. Genomic DNA was extracted with an Easy-DNA kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The presence of erm and mef class genes was determined by PCR amplification using previously described primers specific for erm(A), erm(B), erm(C) and mef(A). 4, 5 
Results
Of the 106 VGS, 32 isolates were identified as Streptococcus mitis; other species included Streptococcus oralis (25 isolates), Streptococcus salivarius (nine isolates), Streptococcus anginosus (eight isolates), Streptococcus parasanguinis (eight isolates), Streptococcus sanguinis (five isolates), Streptococcus constellatus (four isolates), Streptococcus vestivularius (four isolates), Gemella morbillorum (four isolates) and others (seven isolates). Using the agar dilution method, the rates of non-susceptibility were 58% for penicillin G (MIC ≥ 0.25 mg/L), 9% for ceftriaxone (MIC ≥ 2 mg/L), 18% for clindamycin (MIC ≥ 0.5 mg/L) and 34% for erythromycin (MIC ≥ 0.5 mg/L), whereas all isolates were susceptible to vancomycin. Of the 61 penicillin non-susceptible strains, nine were fully resistant to penicillin (range 4-16 mg/L) and 52 showed intermediate susceptibility (range 0.25-2 mg/L). The rates of susceptibility to erythromycin varied according to penicillin susceptibility: 87% in penicillin-susceptible isolates, 56% in penicillinintermediate isolates and 22% in penicillin-resistant isolates. VGS non-susceptible to penicillin were also more resistant to clindamycin and ceftriaxone than penicillin-susceptible strains (Table 1) .
Nineteen (53%) of 36 erythromycin-resistant isolates were resistant to clindamycin. Isolates non-susceptible to both penicillin and erythromycin comprised 28% (n = 30) of all the isolates.
Among (Table 2) . Since strains positive for erm genes were not further tested for mef genes, we do not know how many isolates might have had both resistance mechanisms.
Discussion
Until the 1980s, VGS were considered to be uniformly susceptible to β-lactam antibiotics, but resistance spread rapidly in the 1990s. The prevalence of penicillin non-susceptible VGS varies between studies; in our study, the rate was 58% (intermediate 49% and resistant 9%). The susceptibility rate seen in this study is similar to that reported in the USA 6 (44%), but lower than that of previously reported multicentre studies 1 (61.9-70.3%). As reported in other studies, 1, 7 VGS that were not susceptible to penicillin also showed reduced susceptibility to ceftriaxone, erythromycin and clindamycin. Penicillin resistance in the VGS is mediated by the presence of the mosaic genes encoding altered penicillin-binding proteins with decreased affinity for β-lactam antibiotics. These determinants can be transferred between the VGS and Streptococcus pneumoniae. 8 Therefore, the penicillin-resistant VGS constitute a potential pool of genes for the development of peni- 
cillin resistance in S. pneumoniae and other streptococci. The genes conferring resistance to non-β-lactam antimicrobials, such as macrolides, ciprofloxacin, trimethoprim-sulfamethoxazole and chloramphenicol, are not known to be closely linked to the resistance determinant for penicillin. Increased rates of macrolide resistance in blood isolates of the VGS have been reported in recent years, and the rate of erythromycin resistance noted in our study (34%) was similar to those reported among blood culture isolates in the USA (41%), Canada (38.1%) and northern Taiwan (35%). 1, 6, 7 These rates limit the value of macrolides as prophylaxis in high-risk populations or as a treatment of viridans streptococcal bacteraemia or endocarditis.
The rate of clindamycin resistance in VGS has been determined mainly by the distribution of MLS B resistance phenotypes. In Taiwan, Teng et al. 7 documented that all macrolide-resistant VGS were constitutively resistant. However, in studies reported by western countries, resistance rates to clindamycin were lower than that of erythromycin. 1 In this study, a constitutive MLS B phenotype was the most frequent mechanism observed among erythromycin-resistant isolates (61.1%). The M phenotype was expressed by 36.1% of isolates; this rate is higher than that reported by Teng et al., 7 but lower than that reported by Ioannidou et al. 8 This difference of distribution of MLS B phenotypes may be explained by geographical variation and source of the isolates.
In conclusion, we found high rates of non-susceptibility to penicillin and macrolides among VGS in Korea, and found that a constitutive MLS B phenotype associated with erm(B) was dominant. The high frequency of non-susceptibility to penicillin and macrolides among the VGS limits the use of these drugs as therapeutic or prophylactic agents for bacteraemias caused by these organisms. Our findings indicate clearly that clinical microbiology laboratories should carry out periodic surveillance of antibiotic susceptibility among various species of VGS. Further studies are needed to determine the suitable antimicrobial agents for chemoprophylaxis.
